187 related articles for article (PubMed ID: 10496668)
1. Solid state assay of ranitidine HCl as a bulk drug and as active ingredient in tablets using DRIFT spectroscopy with artificial neural networks.
Agatonovic-Kustrin S; Tucker IG; Schmierer D
Pharm Res; 1999 Sep; 16(9):1477-82. PubMed ID: 10496668
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine hydrochloride X-ray assay using a neural network.
Agatonovic-Kustrin S; Wu V; Rades T; Saville D; Tucker IG
J Pharm Biomed Anal; 2000 Jul; 22(6):985-92. PubMed ID: 10857567
[TBL] [Abstract][Full Text] [Related]
3. Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD.
Agatonovic-Kustrin S; Rades T; Wu V; Saville D; Tucker IG
J Pharm Biomed Anal; 2001 Jul; 25(5-6):741-50. PubMed ID: 11377056
[TBL] [Abstract][Full Text] [Related]
4. Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride.
Agatonovic-Kustrin S; Wu V; Rades T; Saville D; Tucker IG
Int J Pharm; 1999 Jul; 184(1):107-14. PubMed ID: 10425356
[TBL] [Abstract][Full Text] [Related]
5. Prediction of drug content and hardness of intact tablets using artificial neural network and near-infrared spectroscopy.
Chen Y; Thosar SS; Forbess RA; Kemper MS; Rubinovitz RL; Shukla AJ
Drug Dev Ind Pharm; 2001 Aug; 27(7):623-31. PubMed ID: 11694009
[TBL] [Abstract][Full Text] [Related]
6. [Application of an artificial neural network in the design of sustained-release dosage forms].
Wei XH; Wu JJ; Liang WQ
Yao Xue Xue Bao; 2001 Sep; 36(9):690-4. PubMed ID: 12580110
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a method for active drug identification and content determination of ranitidine in pharmaceutical products using near-infrared reflectance spectroscopy: a parametric release approach.
Rosa SS; Barata PA; Martins JM; Menezes JC
Talanta; 2008 May; 75(3):725-33. PubMed ID: 18585138
[TBL] [Abstract][Full Text] [Related]
8. [The Identification of the Origin of Chinese Wolfberry Based on Infrared Spectral Technology and the Artificial Neural Network].
Li Z; Liu MD; Ji SX
Guang Pu Xue Yu Guang Pu Fen Xi; 2016 Mar; 36(3):720-3. PubMed ID: 27400513
[TBL] [Abstract][Full Text] [Related]
9. Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms.
Mirmehrabi M; Rohani S; Murthy KS; Radatus B
Int J Pharm; 2004 Sep; 282(1-2):73-85. PubMed ID: 15336383
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
11. In vitro stability of ranitidine hydrochloride in enteral nutrient formulas.
Crowther RS; Bellanger R; Szauter KE
Ann Pharmacother; 1995 Sep; 29(9):859-62. PubMed ID: 8547732
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
13. An environmentally friendly reflectometric method for ranitidine determination in pharmaceuticals and human urine.
Lima LS; Weinert PL; Lemos SC; Sequinel R; Pezza HR; Pezza L
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1999-2004. PubMed ID: 18783980
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets.
Chen Y; Jiao T; McCall TW; Baichwal AR; Meyer MC
Pharm Dev Technol; 2002; 7(3):373-9. PubMed ID: 12229268
[TBL] [Abstract][Full Text] [Related]
15. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research.
Agatonovic-Kustrin S; Beresford R
J Pharm Biomed Anal; 2000 Jun; 22(5):717-27. PubMed ID: 10815714
[TBL] [Abstract][Full Text] [Related]
16. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
Agatonovic-Kustrin S; Glass BD; Mangan M; Smithson J
Int J Pharm; 2008 Sep; 361(1-2):245-50. PubMed ID: 18555626
[TBL] [Abstract][Full Text] [Related]
17. Application of near-infrared reflectance spectrometry to the analytical control of pharmaceuticals: ranitidine hydrochloride tablet production.
Dreassi E; Ceramelli G; Corti P; Perruccio PL; Lonardi S
Analyst; 1996 Feb; 121(2):219-22. PubMed ID: 8849039
[TBL] [Abstract][Full Text] [Related]
18. Optimization of metformin HCl 500 mg sustained release matrix tablets using Artificial Neural Network (ANN) based on Multilayer Perceptrons (MLP) model.
Mandal U; Gowda V; Ghosh A; Bose A; Bhaumik U; Chatterjee B; Pal TK
Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):150-5. PubMed ID: 18239298
[TBL] [Abstract][Full Text] [Related]
19. Determination of compound aminopyrine phenacetin tablets by using artificial neural networks combined with principal components analysis.
Dou Y; Mi H; Zhao L; Ren Y; Ren Y
Anal Biochem; 2006 Apr; 351(2):174-80. PubMed ID: 16359633
[TBL] [Abstract][Full Text] [Related]
20. Combined wavelet transform-artificial neural network use in tablet active content determination by near-infrared spectroscopy.
Chalus P; Walter S; Ulmschneider M
Anal Chim Acta; 2007 May; 591(2):219-24. PubMed ID: 17481412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
